HD-OPM Archive
Topics › Blood pressure, salt & potassium

Network meta-analysis of 716 trials: ARB-based regimens had fewest BP drug dropouts

Louis Nervegna · Jun 23, 2026 · ♥ 5 reactions · 1 comments · original Facebook post
Blood pressure, salt & potassium
AI summary & key facts

Louis shares the JAMA network meta-analysis of 716 short-term randomized trials comparing discontinuation due to adverse events across blood pressure drug classes. ARB-containing regimens, especially ARB plus calcium channel blocker, had fewer discontinuations than placebo, while CCB monotherapy had more.

Also see this previous post on the study: facebook.com/share/v/1GZoJWGHrE.

#bloodpressureHD #hypertensionHD #arbsHD #jamaHD

Research cited

Shared from JAMA · original post

A network meta-analysis of 716 short-term randomized clinical trials found that discontinuation rates due to adverse events from blood pressure–lowering drugs varied substantially by class and combination.

Regimens containing angiotensin II receptor blockers (#ARBs), especially ARB plus calcium channel blocker (#CCB), were associated with fewer treatment discontinuations than placebo, while CCB monotherapy and certain combinations had higher discontinuation rates.

All drug regimens increased dizziness, but most reduced headache compared with placebo. Several combination therapies were better tolerated than monotherapies, providing important insights for antihypertensive regimen selection.

Paper · JAMA · 2026Adverse Effects and Treatment Discontinuation of Blood Pressure–Lowering Drugs and CombinationsImportance Adverse drug effects from blood pressure (BP)–lowering drugs contribute to significant undertreatment and poor overall BP control rates. Objective To review adverse effects and discontinuation of BP-lowering drugs and their combinations from the 5 major classes in short-term clinical trials. Data Sources and Study Selection Cochrane Central Register of Controlled Trials for randomized clinical trials,…jamanetwork.comNo photo description available.
← newer: Curcumin has the strongest natural-product evidence for loweolder: ARBs, alone or with a calcium channel blocker, are best-tole →